{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:15:03Z","timestamp":1778868903358,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["IV-109-GP-09"],"award-info":[{"award-number":["IV-109-GP-09"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["COVID-19"],"award-info":[{"award-number":["COVID-19"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.bj.2020.06.003","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T21:41:05Z","timestamp":1591393265000},"page":"375-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development"],"prefix":"10.1016","volume":"43","author":[{"given":"Sheng-Wen","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Hui","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-Mei","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayna","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Jhen","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kit Man","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4127-4046","authenticated-orcid":false,"given":"Jen-Ren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bj.2020.06.003_bib1","first-page":"31","article-title":"Emerging and reemerging human viral diseases","volume":"2","author":"Jaijyan","year":"2018","journal-title":"Ann Microbiol Res"},{"key":"10.1016\/j.bj.2020.06.003_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/genetics\/157.1.7","article-title":"Evidence for positive selection in foot-and-mouth disease virus capsid genes from field isolates","volume":"157","author":"Haydon","year":"2001","journal-title":"Genetics"},{"key":"10.1016\/j.bj.2020.06.003_bib3","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1371\/journal.pbio.0030300","article-title":"Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses","volume":"3","author":"Holmes","year":"2005","journal-title":"PLoS Biol"},{"key":"10.1016\/j.bj.2020.06.003_bib4","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1099\/vir.0.060004-0","article-title":"Recombination strategies and evolutionary dynamics of the Human enterovirus A global gene pool","volume":"95","author":"Lukashev","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.bj.2020.06.003_bib5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fmicb.2011.00272","article-title":"Development and applications of VSV vectors based on cell tropism","volume":"2","author":"Tani","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bj.2020.06.003_bib6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/sj.gt.3302715","article-title":"Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors","volume":"13","author":"McKay","year":"2006","journal-title":"Gene Ther"},{"key":"10.1016\/j.bj.2020.06.003_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jviromet.2008.07.015","article-title":"Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies","volume":"153","author":"Wang","year":"2008","journal-title":"J Virol Method"},{"key":"10.1016\/j.bj.2020.06.003_bib8","series-title":"Gene therapy - tools and potential applications","article-title":"Targeted lentiviral vectors: current applications and future potential","author":"Goyvaerts","year":"2013"},{"key":"10.1016\/j.bj.2020.06.003_bib9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/22221751.2019.1571871","article-title":"Nipah pseudovirus system enables evaluation of vaccines in\u00a0vitro and in\u00a0vivo using non-BSL-4 facilities","volume":"8","author":"Nie","year":"2019","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.bj.2020.06.003_bib10","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1080\/21645515.2017.1325050","article-title":"A bioluminescent imaging mouse model for Marburg virus based on a pseudovirus system","volume":"13","author":"Zhang","year":"2017","journal-title":"Hum Vaccine Immunother"},{"key":"10.1016\/j.bj.2020.06.003_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110893","article-title":"Chikungunya virus glycoproteins pseudotype with lentiviral vectors and reveal a broad spectrum of cellular tropism","volume":"9","author":"Hu","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.bj.2020.06.003_bib12","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.bj.2020.06.003_bib13","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1128\/JVI.00161-14","article-title":"Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection","volume":"88","author":"Barlan","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.bj.2020.06.003_bib14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/1743-422X-10-266","article-title":"A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV","volume":"10","author":"Zhao","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.bj.2020.06.003_bib15","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1099\/vir.0.80955-0","article-title":"Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein","volume":"86","author":"Fukushi","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.bj.2020.06.003_bib16","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.0306446101","article-title":"Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry","volume":"101","author":"Simmons","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bj.2020.06.003_bib17","doi-asserted-by":"crossref","first-page":"14764","DOI":"10.1073\/pnas.94.26.14764","article-title":"A system for functional analysis of Ebola virus glycoprotein","volume":"94","author":"Takada","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bj.2020.06.003_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jviromet.2014.09.021","article-title":"Lyophilisation of influenza, rabies and Marburg lentiviral pseudotype viruses for the development and distribution of a neutralisation -assay-based diagnostic kit","volume":"210","author":"Mather","year":"2014","journal-title":"J Virol Method"},{"key":"10.1016\/j.bj.2020.06.003_bib19","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1016\/j.vaccine.2017.07.101","article-title":"An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions","volume":"35","author":"Li","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.bj.2020.06.003_bib20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0042-6822(75)90284-6","article-title":"Activation of influenza A viruses by trypsin treatment","volume":"68","author":"Klenk","year":"1975","journal-title":"Virology"},{"key":"10.1016\/j.bj.2020.06.003_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/viro.1994.1489","article-title":"Cell tropism of influenza virus mediated by hemagglutinin activation at the stage of virus entry","volume":"203","author":"Boycott","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.bj.2020.06.003_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.1999.9716","article-title":"Role of hemagglutinin cleavage for the pathogenicity of influenza virus","volume":"258","author":"Steinhauer","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.bj.2020.06.003_bib23","doi-asserted-by":"crossref","first-page":"8683","DOI":"10.1128\/JVI.00797-10","article-title":"Modifications to the hemagglutinin cleavage site control the virulence of a neurotropic H1N1 influenza virus","volume":"84","author":"Sun","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.bj.2020.06.003_bib24","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1073\/pnas.0809524106","article-title":"Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites","volume":"106","author":"Belouzard","year":"2009","journal-title":"Proc Natl Acad Sci Unit States Am"},{"key":"10.1016\/j.bj.2020.06.003_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01282-19","article-title":"Peptidoglycan-associated cyclic lipopeptide disrupts viral infectivity","volume":"93","author":"Johnson","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.bj.2020.06.003_bib26","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.virol.2006.02.003","article-title":"Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell\u2013cell fusion but does not affect virion entry","volume":"350","author":"Follis","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.bj.2020.06.003_bib27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virusres.2014.11.021","article-title":"Host cell proteases: critical determinants of coronavirus tropism and pathogenesis","volume":"202","author":"Millet","year":"2015","journal-title":"Virus Res"},{"key":"10.1016\/j.bj.2020.06.003_bib28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3201\/eid1103.040906","article-title":"Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes","volume":"11","author":"Temperton","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bj.2020.06.003_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/21645515.2017.1373922","article-title":"Development and optimization of a sensitive pseudovirus-based assay for HIV-1 neutralizing antibodies detection using A3R5 cells","volume":"14","author":"Chen","year":"2018","journal-title":"Hum Vaccine Immunother"},{"key":"10.1016\/j.bj.2020.06.003_bib30","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/22221751.2020.1743767","article-title":"Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2","volume":"9","author":"Nie","year":"2020","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.bj.2020.06.003_bib31","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.bbrc.2010.05.161","article-title":"Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies","volume":"397","author":"Du","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bj.2020.06.003_bib32","article-title":"Development and evaluation of a pseudovirus-luciferase assay for rapid and quantitative detection of neutralizing antibodies against enterovirus 71","volume":"8","author":"Wu","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.bj.2020.06.003_bib33","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/v10090448","article-title":"A human DPP4-knockin mouse's susceptibility to infection by authentic and pseudotyped MERS-CoV","volume":"10","author":"Fan","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.bj.2020.06.003_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41541-019-0104-x","article-title":"A recombinant vesicular stomatitis-based Lassa fever vaccine elicits rapid and long-term protection from lethal Lassa virus infection in Guinea pigs","volume":"4","author":"Stein","year":"2019","journal-title":"NPJ Vaccine"},{"key":"10.1016\/j.bj.2020.06.003_bib35","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bj.2020.06.003_bib36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/22221751.2019.1702479","article-title":"HIV-1 pseudoviruses constructed in China regulatory laboratory","volume":"9","author":"Nie","year":"2020","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.bj.2020.06.003_bib37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1134\/S1607672910060049","article-title":"A pseudovirus system for the testing of antiviral activity of compounds in different cell lines","volume":"435","author":"Cheresiz","year":"2010","journal-title":"Dokl Biochem Biophys"},{"key":"10.1016\/j.bj.2020.06.003_bib38","first-page":"e4031","article-title":"Production of lentiviral vectors for transducing cells from the central nervous system","volume":"63","author":"Li","year":"2012","journal-title":"J Vis Exp"},{"key":"10.1016\/j.bj.2020.06.003_bib39","doi-asserted-by":"crossref","first-page":"12543","DOI":"10.1073\/pnas.0503203102","article-title":"Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection","volume":"102","author":"Matsuyama","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bj.2020.06.003_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bj.2020.06.003_bib41","doi-asserted-by":"crossref","first-page":"e00307","DOI":"10.1128\/mBio.00307-19","article-title":"Antigenic drift of the influenza A(H1N1)pdm09 virus neuraminidase results in reduced effectiveness of A\/California\/7\/2009 (H1N1pdm09)-specific antibodies","volume":"10","author":"Gao","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.bj.2020.06.003_bib42","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1128\/JCM.00630-09","article-title":"Reemergence of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008","volume":"47","author":"Huang","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bj.2020.06.003_bib43","doi-asserted-by":"crossref","first-page":"11500","DOI":"10.1128\/JVI.02035-15","article-title":"Mapping enterovirus A71 antigenic determinants from viral evolution","volume":"89","author":"Huang","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.bj.2020.06.003_bib44","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1126\/science.aac5017","article-title":"Dengue viruses cluster antigenically but not as discrete serotypes","volume":"349","author":"Katzelnick","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bj.2020.06.003_bib45","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1126\/science.1244730","article-title":"Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution","volume":"342","author":"Koel","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bj.2020.06.003_bib46","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"Smith","year":"2004","journal-title":"Science"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417020300901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417020300901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:50:21Z","timestamp":1778867421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2319417020300901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2319417020300901"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2020.06.003","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2020.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Chang Gung University. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}